Skip Navigation


Brain Advance Access originally published online on November 21, 2006
Brain 2007 130(2):535-547; doi:10.1093/brain/awl317
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrowOA All Versions of this Article:
130/2/535    most recent
awl317v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (14)
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Ivens, S.
Right arrow Articles by Friedman, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ivens, S.
Right arrow Articles by Friedman, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2006 The Author(s)
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

TGF-ß receptor-mediated albumin uptake into astrocytes is involved in neocortical epileptogenesis

Sebastian Ivens1, Daniela Kaufer3,4, Luisa P Flores3, Ingo Bechmann2, Dominik Zumsteg5, Oren Tomkins6, Ernst Seiffert1, Uwe Heinemann1 and Alon Friedman1,6

1 Institute of Neurophysiology, Charité University Medicine Berlin, Germany 2 Center of Anatomy, Charité University Medicine Berlin, Germany 3 Department of Integrative Biology, UC Berkeley Berkeley, CA, USA 4 Helen Wills Neuroscience Institute, UC Berkeley Berkeley, CA, USA 5 Krembil Neuroscience Centre, Toronto Western Hospital, University of Toronto Toronto, ON, Canada 6 Departments of Physiology and Neurosurgery, Zlotowski Center for Neuroscience, Ben-Gurion University of the Negev Beer-Sheva, Israel

Correspondence to: Dr Alon Friedman, Departments of Physiology and Neurosurgery, Soroka University Medical Centre and Zlotowski Center for Neuroscience, Ben-Gurion University, Beer-Sheva 84105, Israel E-mail: alonf{at}bgu.ac.il

It has long been recognized that insults to the cerebral cortex, such as trauma, ischaemia or infections, may result in the development of epilepsy, one of the most common neurological disorders. Human and animal studies have suggested that perturbations in neurovascular integrity and breakdown of the blood–brain barrier (BBB) lead to neuronal hypersynchronization and epileptiform activity, but the mechanisms underlying these processes are not known. In this study, we reveal a novel mechanism for epileptogenesis in the injured brain. We used focal neocortical, long-lasting BBB disruption or direct exposure to serum albumin in rats (51 and 13 animals, respectively, and 26 controls) as well as albumin exposure in brain slices in vitro. Most treated slices (72%, n = 189) displayed hypersynchronous propagating epileptiform field potentials when examined 5–49 days after treatment, but only 14% (n = 71) of control slices showed similar responses. We demonstrate that direct brain exposure to serum albumin is associated with albumin uptake into astrocytes, which is mediated by transforming growth factor ß receptors (TGF-ßRs). This uptake is followed by down regulation of inward-rectifying potassium (Kir 4.1) channels in astrocytes, resulting in reduced buffering of extracellular potassium. This, in turn, leads to activity-dependent increased accumulation of extracellular potassium, resulting in facilitated N-methyl-D-aspartate-receptor-mediated neuronal hyperexcitability and eventually epileptiform activity. Blocking TGF-ßR in vivo reduces the likelihood of epileptogenesis in albumin-exposed brains to 29.3% (n = 41 slices, P < 0.05). We propose that the above-described cascade of events following common brain insults leads to brain dysfunction and eventually epilepsy and suggest TGF-ßRs as a possible therapeutic target.

Key Words: astrocytes; blood–brain barrier; epileptogenesis; neocortex; transforming growth factor beta receptors

Abbreviations: ACSF, artificial CSF; BBB, blood–brain barrier; DOC, deoxycholic acid; FITC, fluorescein isothiocyanate; GFAP, glial fibrillary acidic protein; [K+]o, extracellular potassium concentration; NMDA, N-methyl-D-aspartate; TGF-ßRs, transforming growth factor ß receptors

Received June 8, 2006. Revised September 19, 2006. Accepted October 14, 2006.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Neurol. Neurosurg. PsychiatryHome page
O Tomkins, I Shelef, I Kaizerman, A Eliushin, Z Afawi, A Misk, M Gidon, A Cohen, D Zumsteg, and A Friedman
Blood-brain barrier disruption in post-traumatic epilepsy
J. Neurol. Neurosurg. Psychiatry, July 1, 2008; 79(7): 774 - 777.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
E.A. van Vliet and J.A. Gorter
Reply: Complexities in the association of human blood brain barrier disruption with seizures: importance of patient population and method of disruption
Brain, August 1, 2007; 130(8): e78 - e78.
[Full Text] [PDF]


Home page
BrainHome page
V. Rigau, M. Morin, M.-C. Rousset, F. de Bock, A. Lebrun, P. Coubes, M.-C. Picot, M. Baldy-Moulinier, J. Bockaert, A. Crespel, et al.
Angiogenesis is associated with blood-brain barrier permeability in temporal lobe epilepsy
Brain, July 1, 2007; 130(7): 1942 - 1956.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.